MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) Gains 10% After Receiving DTC Eligibility

MediPharm Labs Corp.

MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) is a global leader in the cannabis extraction space. The company focuses on specialized and research-driven extraction, distillation, purification, and isolation. The cannabis extraction company’s Canadian-listed shares are gaining 10%, through afternoon trading on Tuesday, April 16, 2019. Over the past three months, MediPharm Labs has seen average daily volume of 858,047 shares.…

Read More

Here’s What’s Really Happening with Canopy Growth Corp (TSX:WEED)

If you’re like me and have been watching Canopy Growth  (TSX:WEED)(NYSE:CGC) over the past year, you’re probably pretty dizzy by now. The stock was on such a great trend, reaching the $70 range, when October hit — and hit hard. As you’re probably aware, share dropped to more than 50% where they once were, leaving investors scrambling. Then things started to…

Read More

Why Did CannTrust Holdings (TSX:TRST) Stock Fall 19% on Thursday?

Marijuana stock CannTrust Holdings (TSX:TRST)(NYSE:CTST) traded sharply lower on March 28 after the once highly profitable cannabis firm released fourth quarter and full-year 2018 results before market open in the morning that shocked the loyal investing public. Shares closed 19% lower, and the big question is whether the latest set of financial results was disappointing enough to justify such a large…

Read More

Captor Capital Announces Letter of Intent to Acquire Premiere THC Manufacturing Facility from People’s Holdings

Captor Capital Corp

TORONTO, March 29, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), a vertically integrated cannabis-focused investment company, is pleased to announce that a wholly owned subsidiary of the Company has entered into a Letter of Intent (“LOI”) to acquire 100 per cent ownership of a Type 7 Volatile Solvent…

Read More

Captor Capital Extracts More Growth

Captor Capital (CSE: CPTR; FRANKFURT: NMV; USOTC: NWURD) continues to grow its position in the cannabis sector. Investors learned that the company successfully sealed the acquisition of Mellow Extracts, LLC (“Mellow”), which will produce ultra-premium oil in a state-of-the-art extraction lab facility in Costa Mesa, California. In addition to this, Mellow will provide oils and premium concentrates to Captor’s retail…

Read More